March 4, 2010
Gilead Sciences to Present at the Cowen and Company 30th Annual Health Care Conference on Thursday, March 11

February 22, 2010
U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa

February 17, 2010
Gilead's Single-Tablet "Quad" Regimen for HIV Achieves a High Rate of Virologic Suppression in Phase II Study

February 2, 2010
Gilead Sciences to Present at the 12th Annual BIO CEO Investor Conference on Tuesday, February 9

January 29, 2010
Gilead Announces Share Repurchase Program

January 28, 2010
Per Wold-Olsen Joins Gilead Sciences' Board of Directors

January 27, 2010
Gilead Sciences Announces Notification of ANDA Filing for Viread®

January 26, 2010
Gilead Sciences Announces Record Fourth Quarter and Full Year 2009 Financial Results

January 19, 2010
Gilead Sciences to Release Fourth Quarter and Year End 2009 Financial Results on Tuesday, January 26, 2010

January 6, 2010
Phase II Clinical Trial of Gilead's Investigational Integrase-Based, Once-Daily, Fixed-Dose "Quad"Regimen Meets 24-Week Primary Objective

January 4, 2010
Gilead Sciences to Present at Two Upcoming Investor Conferences